Martha: Guilty on All Counts

After hearing the jury's verdict, and as her lawyer vowed to appeal, a defiant Stewart once again insisted that she is innocent

A jury has convicted Martha Stewart of lying to federal investigators about her sale of 3,298 shares of ImClone (IMCL ) stock on Dec. 27, 2001, the day before the Food & Drug Administration rejected the drug outfit's application for Erbitux, a cancer drug. The four charges carry a possible sentence of up to 20 years in prison.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.